Advanced search
Start date

Docetaxel loaded-immunoliposomes: in vitro effect in 3D multicellular tumor spheroids of prostate cancer cell culture

Grant number: 18/21104-2
Support Opportunities:Scholarships abroad - Research Internship - Scientific Initiation
Effective date (Start): January 15, 2019
Effective date (End): May 14, 2019
Field of knowledge:Health Sciences - Pharmacy - Pharmaceutical Technology
Principal Investigator:Marlus Chorilli
Grantee:Felipe Tita de Lima
Supervisor: Wafa Al-Jamal
Host Institution: Faculdade de Ciências Farmacêuticas (FCFAR). Universidade Estadual Paulista (UNESP). Campus de Araraquara. Araraquara , SP, Brazil
Research place: Queen's University Belfast, Northern Ireland  
Associated to the scholarship:18/00814-1 - Development and characterization of lyophilized liposomes and immunoliposomes containing docetaxel for potential application in the prostate cancer treatment, BP.IC


Prostate cancer is the second most common type of cancer worldwide, which indicates a serious public health problem. Docetaxel is one of the main chemotherapeutic agents for the treatment, even though some of its physicochemical properties limit its therapeutic use, such as low solubility in water and toxicity. Encapsulation in nanocarriers, especially liposomes, has the potential to improve docetaxel's properties. However, as liposomal formulations may face physico-chemical instability in aqueous dispersions, it is necessary to employ methods to prolong liposome stability, the freeze-drying being the most common of those methods. The functionalization of liposomes with monoclonal antibodies has the potential to increase the selectivity and efficacy of the treatment. Thus, cetuximab is a monoclonal antibody potentially applicable for prostate cancer treatment, since cancer cells can overexpress the EGFR (Epidermal Growth Factor Receptor), which binds to cetuximab. Therefore, the strategy of functionalized liposomes with cetuximab is potentially advantageous. Thus, this study will consist of characterization and in vitro evaluation of cetuximab conjugated liposomes, prepared by the classic thin lipid film method and extrusion, containing encapsulated docetaxel, in 3D multicellular tumor spheroids (MTS) of a prostate cancer cell culture (DU145). The efficacy of the formulations will be investigated by cell cytotoxicity and the uptake cellular will be evaluated by confocal microscopy and flow cytometry. (AU)

News published in Agência FAPESP Newsletter about the scholarship:
Articles published in other media outlets (0 total):
More itemsLess items

Scientific publications
(References retrieved automatically from Web of Science and SciELO through information on FAPESP grants and their corresponding numbers as mentioned in the publications by the authors)
ELOY, JOSIMAR O.; RUIZ, AMALIA; DE LIMA, FELIPE TITA; PETRILLI, RAQUEL; RASPANTINI, GIOVANNI; BARROS NOGUEIRA, KARINA ALEXANDRE; SANTOS, ELIAS; DE OLIVEIRA, CARLOS SABINO; BORGES, JULIO CESAR; MARCHETTI, JULIANA MALDONADO; et al. EGFR-targeted immunoliposomes efficiently deliver docetaxel to prostate cancer cells. COLLOIDS AND SURFACES B-BIOINTERFACES, v. 194, p. 12-pg., . (18/21104-2, 18/00814-1, 17/04091-1, 16/02723-8)

Please report errors in scientific publications list using this form.